Publicado 6 números por año
ISSN Imprimir: 0743-4863
ISSN En Línea: 2162-660X
Indexed in
Potential Approaches for Drug Delivery to the Brain: Past, Present, and Future
SINOPSIS
The objective of this article is to provide the reader with an update on some research highlights from the past to the present, as well as future possibilities to achieve improved delivery of drugs across the blood–brain barrier (BBB). In the past, dye studies confirmed the presence of the BBB and blood–cerebrospinal fluid barriers, which seem to play a major role in transporting drug molecules for the treatment of life-threatening diseases such as brain cancer and Alzheimer's. Presently, transportation mechanisms such as simple diffusion, carrier-mediated, absorptive-mediated, and receptor-mediated transcytosis are extensively used for BBB uptake of drug molecules. The spectrum of future neuropharmaceuticals falling into these categories ranges from peptides to nucleotide-based drugs as well as gene and stem cell deli very agents, and is increasing at a rapid rate with promising results. There has also been considerable progress in the development of quantitative methods to examine BBB permeability in humans and animals. Currently, intravenous administration and in situ brain perfusion techniques are the most versatile and sensitive methods to measure transport into the brain. This article also reviews the various methodologies available for assessing the transfer of drug molecules undergoing significant uptake through the BBB in vivo.
-
Daneman Richard, The blood-brain barrier in health and disease, Annals of Neurology, 72, 5, 2012. Crossref
-
Davies Michael A., Targeted Therapy for Brain Metastases, in Current Challenges in Personalized Cancer Medicine, 65, 2012. Crossref
-
Siegal T., Which drug or drug delivery system can change clinical practice for brain tumor therapy?, Neuro-Oncology, 15, 6, 2013. Crossref
-
Jain Aviral, Singhai Priyanka, Gurnany Ekta, Updhayay Satish, Mody Nishi, Transferrin-tailored solid lipid nanoparticles as vectors for site-specific delivery of temozolomide to brain, Journal of Nanoparticle Research, 15, 3, 2013. Crossref
-
Chun Hyun Bae, Scott Michael, Niessen Sherry, Hoover Heather, Baird Andrew, Yates John, Torbett Bruce E, Eliceiri Brian P, The Proteome of Mouse Brain Microvessel Membranes and Basal Lamina, Journal of Cerebral Blood Flow & Metabolism, 31, 12, 2011. Crossref
-
Neves Vera, Aires-da-Silva Frederico, Corte-Real Sofia, Castanho Miguel A.R.B., Antibody Approaches To Treat Brain Diseases, Trends in Biotechnology, 34, 1, 2016. Crossref
-
Nicolas Jean-Marie, Species Differences and Impact of Disease State on BBB, in Blood-Brain Barrier in Drug Discovery, 2015. Crossref
-
Liguori Lavinia, Pastorino Fabio, Rousset Xavier, Alfano Silvia, Cortes Sandra, Emionite Laura, Daga Antonio, Ponzoni Mirco, Lenormand Jean-Luc, Anti-Tumor Effects of Bak-Proteoliposomes against Glioblastoma, Molecules, 20, 9, 2015. Crossref
-
Jain Aviral, Chasoo Gousia, Singh Shashank K., Saxena Ajit K., Jain Sanjay K., Transferrin-appended PEGylated nanoparticles for temozolomide delivery to brain:in vitrocharacterisation, Journal of Microencapsulation, 28, 1, 2011. Crossref
-
Daneman Richard, Engelhardt Britta, Brain barriers in health and disease, Neurobiology of Disease, 107, 2017. Crossref
-
de Luca Emanuela, Marinaro Federica, Niola Francesco, Tonelli Davide De Pietri, Cutting Edge Approaches for the Identification and the Functional Investigation of miRNAs in Brain Science, in Handbook of Neurobehavioral Genetics and Phenotyping, 2017. Crossref
-
Guerra M., Blázquez J. L., Rodríguez E. M., Blood–brain barrier and foetal-onset hydrocephalus, with a view on potential novel treatments beyond managing CSF flow, Fluids and Barriers of the CNS, 14, 1, 2017. Crossref
-
Pohl-Guimarães Fernanda, Yang Changlin, Dyson Kyle A., Wildes Tyler J., Drake Jeffrey, Huang Jianping, Flores Catherine, Sayour Elias J., Mitchell Duane A., RNA-Modified T Cells Mediate Effective Delivery of Immunomodulatory Cytokines to Brain Tumors, Molecular Therapy, 27, 4, 2019. Crossref
-
Antimisiaris Sophia, Mourtas Spyridon, Papadia Konstantina, Brain targeting with lipidic nanocarriers, in Design of Nanostructures for Versatile Therapeutic Applications, 2018. Crossref
-
Agrawal Mukta, Saraf Swarnlata, Saraf Shailendra, Antimisiaris Sophia G., Hamano Nobuhito, Li Shyh-Dar, Chougule Mahavir, Shoyele Sunday A., Gupta Umesh, Ajazuddin , Alexander Amit, Recent advancements in the field of nanotechnology for the delivery of anti-Alzheimer drug in the brain region, Expert Opinion on Drug Delivery, 15, 6, 2018. Crossref
-
Siegal Tali, Which Drug or Drug Delivery Method Can Change Clinical Practice for Brain Tumor Therapy?, in Drug Delivery to the Brain, 10, 2014. Crossref
-
Pandey Vikas, Gadeval Anuradha, Asati Saket, Jain Priyanka, Jain Navneet, Roy Ram Kumar, Tekade Muktika, Soni Vandana, Tekade Rakesh K., Formulation strategies for nose-to-brain delivery of therapeutic molecules, in Drug Delivery Systems, 2020. Crossref
-
Yasaswi P. Soma, Shetty Karishma, Yadav Khushwant S., Temozolomide nano enabled medicine: promises made by the nanocarriers in glioblastoma therapy, Journal of Controlled Release, 336, 2021. Crossref
-
Bussy Cyrill, Al-Jamal Khuloud T., Boczkowski Jorge, Lanone Sophie, Prato Maurizio, Bianco Alberto, Kostarelos Kostas, Microglia Determine Brain Region-Specific Neurotoxic Responses to Chemically Functionalized Carbon Nanotubes, ACS Nano, 9, 8, 2015. Crossref
-
Russell-Jones Gregory, Intestinal receptor targeting for peptide delivery: an expert’s personal perspective on reasons for failure and new opportunities, Therapeutic Delivery, 2, 12, 2011. Crossref
-
Aguiar Sandra Isabel, Dias Joana N. R., André Ana Santos, Silva Marta Lisete, Martins Diana, Carrapiço Belmira, Castanho Miguel, Carriço João, Cavaco Marco, Gaspar Maria Manuela, Nobre Rui Jorge, Pereira de Almeida Luís, Oliveira Soraia, Gano Lurdes, Correia João D. G., Barbas Carlos, Gonçalves João, Neves Vera, Aires-da-Silva Frederico, Highly Specific Blood-Brain Barrier Transmigrating Single-Domain Antibodies Selected by an In Vivo Phage Display Screening, Pharmaceutics, 13, 10, 2021. Crossref
-
Petrenko Daria, Chubarev Vladimir, Syzrantsev Nikita, Ismail Nafeeza, Merkulov Vadim, Sologova Susanna, Grigorevskikh Ekaterina, Smolyarchuk Elena, Alyautdin Renad, Temozolomide Efficacy and Metabolism: The Implicit Relevance of Nanoscale Delivery Systems, Molecules, 27, 11, 2022. Crossref
-
Desai Harita R., Shinde Ujwala A., Hybrid nanoparticles to cross the blood–brain barrier, in Nanocarriers for Drug-Targeting Brain Tumors, 2022. Crossref
-
Zhang Yunhan, Zou Zhulin, Liu Shuang, Miao Shengjie, Liu Haiyan, Nanogels as Novel Nanocarrier Systems for Efficient Delivery of CNS Therapeutics, Frontiers in Bioengineering and Biotechnology, 10, 2022. Crossref
-
Bartusik-Aebisher Dorota, Żołyniak Aleksandra, Barnaś Edyta, Machorowska-Pieniążek Agnieszka, Oleś Piotr, Kawczyk-Krupka Aleksandra, Aebisher David, The Use of Photodynamic Therapy in the Treatment of Brain Tumors—A Review of the Literature, Molecules, 27, 20, 2022. Crossref